These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8096074)
21. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608 [TBL] [Abstract][Full Text] [Related]
22. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer. Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532 [TBL] [Abstract][Full Text] [Related]
23. Allelotype of human bladder cancer. Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491 [TBL] [Abstract][Full Text] [Related]
24. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331 [TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer. Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864 [TBL] [Abstract][Full Text] [Related]
26. Role of chromosome 9 in human bladder cancer. Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736 [TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb. Bell SM; Zuo J; Myers RM; Knowles MA Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728 [TBL] [Abstract][Full Text] [Related]
28. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549 [TBL] [Abstract][Full Text] [Related]
29. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685 [TBL] [Abstract][Full Text] [Related]
30. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Cunningham C; Dunlop MG; Wyllie AH; Bird CC Oncogene; 1993 May; 8(5):1391-6. PubMed ID: 8479756 [TBL] [Abstract][Full Text] [Related]
31. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516 [TBL] [Abstract][Full Text] [Related]
32. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124 [TBL] [Abstract][Full Text] [Related]
33. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782 [TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour. Grundy RG; Pritchard J; Scambler P; Cowell JK Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521 [TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642 [TBL] [Abstract][Full Text] [Related]
36. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485 [TBL] [Abstract][Full Text] [Related]
37. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346 [TBL] [Abstract][Full Text] [Related]
38. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558 [TBL] [Abstract][Full Text] [Related]
39. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226 [TBL] [Abstract][Full Text] [Related]